Optimal dialysis for the end-stage renal disease patient with cardiovascular disease.
The increasing incidence and prevalence of end-stage renal disease (ESRD) that requires renal replacement therapy has placed a focus on the dialysis procedure itself with respect to its hemodynamic and cardiovascular complications. More than 50% of patients with ESRD will die of cardiovascular disease (CVD). A considerable contribution to cardiovascular events occurs with the dialysis procedure itself. This paper explores the intradialytic complications of hemodialysis as they relate to the cardiovascular system and highlights opportunities for research and improved quality of care.
Dumler
Francis
F
Department of Medicine, Division of Nephrology, William Beaumont Hospital, Royal Oak, MI 48073, USA. fdumler@beaumont.edu
McCullough
Peter A
PA
D001145:Arrhythmias, Cardiac / Q000209:etiology; D002114:Calcinosis / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology*; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007022:Hypotension / Q000209:etiology; D000860:Hypoxia / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D006435:Renal Dialysis / Q000009:adverse effects*